|
||
|
In vitro EGFR kinase enzymatic inhibitory activity of compound 7. EC50= the effective concentration that inhibits 50% of EGFR kinase activity. |
|
||||||||
| Part of: Al-Bayati AI, Mahmood AAR, Al-Mazaydeh ZA, Rammaha MS, Al-bayati RI, Alsoubani F, Tahtamouni LH (2021) Synthesis, docking study, and in vitro anticancer evaluation of new flufenamic acid derivatives. Pharmacia 68(2): 449-461. https://doi.org/10.3897/pharmacia.68.e66788 |